11/15/2013

The FDA is seeking changes to some topical antiseptics' packaging and labels to lower infection risks. Contamination can take place during production because the sterility of topical antiseptics is not a requirement in the process. Manufacturers are urged by the agency to voluntarily change labels to point out whether a drug is produced as sterile or nonsterile. Also, the FDA is urging that topical antiseptics be manufactured in single-use sizes to avoid contamination by the user.

Related Summaries